-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Pfizer, Lowers Price Target to $27

Benzinga·12/17/2025 15:30:31
Listen to the news
Morgan Stanley analyst Terence Flynn maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $28 to $27.